Fonar (FONR) GF Value : $18.36 (As of Apr. 29, 2024)

View and export this data going back to 1981. Start your Free Trial

What is Fonar GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-29), Fonar's share price is $16.27. Fonar's GF Value is $18.36. Therefore, Fonar's Price-to-GF-Value for today is 0.89.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Fonar is Modestly Undervalued.

Fonar (NAS:FONR) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Fonar's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	16.27	/	18.36
	=	0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fonar GF Value Related Terms

Thank you for viewing the detailed overview of Fonar's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Fonar (FONR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » GF Value

Comparable Companies

STIM NOTV BNR ACRS PRPH VNRX BDSX MDXH BIOQ PSNL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

FOAA:Germany

Address

110 Marcus Drive, Melville, NY, USA, 11747

Website

https://www.fonar.com

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.

Executives

Timothy Raymond Damadian	director, officer: CEO, President & Treasurer	110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni	officer: Exec VP, COO & PFO	110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian	director, officer: president	31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff	director	32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O	director	347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan	director	145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry	officer: Secretary	BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian	director	303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022